AAAAAA

   
Results: 1-3 |
Results: 3
Attention deficit-hyperactivity disorder may be a risk factor for treatment-emergent tardive dyskinesia induced by risperidone
Authors: Silver, H Aharon, N Schwartz, M
Citation: H. Silver et al., Attention deficit-hyperactivity disorder may be a risk factor for treatment-emergent tardive dyskinesia induced by risperidone, J CL PSYCH, 20(1), 2000, pp. 112-114
Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study
Authors: Silver, H Barash, I Aharon, N Kaplan, A Poyurovsky, M
Citation: H. Silver et al., Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study, INT CLIN PS, 15(5), 2000, pp. 257-261
The effect of augmentation with moclobemide on symptoms of schizophrenia
Authors: Silver, H Aharon, N Hausfater, N Jahjah, N
Citation: H. Silver et al., The effect of augmentation with moclobemide on symptoms of schizophrenia, INT CLIN PS, 14(3), 1999, pp. 193-195
Risultati: 1-3 |